Skip to main content

Table 7 Percentage of potential Extended-spectrum β-lactamase (ESβL)-producing gram-negative bacteria and percentage mortality attributed to each of the indicated species of gram-negative bacteria

From: Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients

Species

Resistance to both Cefotaxime and Ceftazidime (Potential ESβL-producers)

In-hospital Mortality Rate

Acinetobacter

62.2%

16%

Escherichia coli

54%

11.9%

Enterobacter species

64%

15%

Klebsiella species

44.8%

8.7%

Pseudomonas species

70.2%

34.1%

Serratia species

62.5%

12.5%